This site looks better in landscape mode

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 50%

Over half of people diagnosed with knee osteoarthritis are under 65 years of age

NEWS

MHRA awards Innovation Passport for APPA in Osteoarthritis

Read More

NEWS

APPA reduces senescence & reactive oxygen species production

Read More

NEWS

New studies suggests APPA protects against joint damage

Read More

NEWS

 

MHRA awards Innovation Passport for APPA in Osteoarthritis

Read More

 

APPA reduces senescence & reactive oxygen species production

Read More

 

New studies suggests APPA protects against joint damage

Read More